Market Exclusive

ABIOMED, Inc. (NASDAQ:ABMD) gets downgraded to Market Perform by Raymond James

Analyst Ratings For ABIOMED, Inc. (NASDAQ:ABMD)

Today, ABIOMED, Inc. (NASDAQ:ABMD) stock was downgraded by Raymond James from Outperform to Market Perform.

There are 4 Hold Ratings, 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on ABIOMED, Inc. (NASDAQ:ABMD) is Hold with a consensus target price of $318.33 per share, a potential 73.09% upside.

Some recent analyst ratings include

Recent Trading Activity for ABIOMED, Inc. (NASDAQ:ABMD)
Shares of ABIOMED, Inc. closed the previous trading session at 183.91 up +1.57 0.86% with 186.26 shares trading hands.

Exit mobile version